Headlines about Ingevity (NYSE:NGVT) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ingevity earned a coverage optimism score of 0.22 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.4949845614542 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Here are some of the media stories that may have effected Accern’s rankings:

A number of equities research analysts have weighed in on the company. KeyCorp reaffirmed an “overweight” rating and set a $89.00 target price (up from $78.00) on shares of Ingevity in a research report on Friday, February 23rd. SunTrust Banks reaffirmed a “buy” rating and set a $90.00 target price on shares of Ingevity in a research report on Friday, February 23rd. Loop Capital decreased their target price on Ingevity from $83.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, December 26th. Zacks Investment Research lowered Ingevity from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Finally, Rowe reaffirmed an “outperform” rating and set a $90.00 target price (up from $80.00) on shares of Ingevity in a research report on Thursday, November 30th. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Ingevity currently has a consensus rating of “Buy” and a consensus target price of $84.14.

Shares of Ingevity (NYSE:NGVT) opened at $75.95 on Monday. The company has a current ratio of 2.40, a quick ratio of 1.36 and a debt-to-equity ratio of 1.60. The firm has a market capitalization of $3,195.60, a price-to-earnings ratio of 25.57, a price-to-earnings-growth ratio of 1.93 and a beta of 0.93. Ingevity has a 1 year low of $53.62 and a 1 year high of $82.10.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Tuesday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.36 by $0.09. Ingevity had a return on equity of 50.75% and a net margin of 12.99%. The business had revenue of $229.50 million for the quarter, compared to the consensus estimate of $214.94 million. During the same period last year, the business posted $0.34 EPS. The business’s revenue was up 8.8% compared to the same quarter last year. equities research analysts predict that Ingevity will post 3.34 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.dailypolitical.com/2018/03/05/ingevity-ngvt-earns-media-sentiment-rating-of-0-22.html.

Ingevity Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

Insider Buying and Selling by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.